Blue Owl Technology Finance Corp. (OTF)

Verve Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover Verve Therapeutics stock have a consensus rating of "Buy" and an average price target of $16.25, which forecasts a 7.54% increase in the stock price over the next year. The lowest target is $15 and the highest is $17.

Price Target: $16.25 (+7.54%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$16.25	$17	$17
Change	-0.73%	+7.54%	+12.51%	+12.51%

Analyst Ratings

The average analyst rating for Verve Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25
Strong Buy	1	2
Buy	0	0
Hold	1	2
Sell	0	0
Strong Sell	0	0
Total	2	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Johnson Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Initiates $16	Hold	Initiates	$16	+5.89%	Jul 14, 2025
Arren Cyganovich Truist Securities	Truist Securities	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+12.51%	Jul 7, 2025
Casey Alexander Compass Point	Compass Point	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+12.51%	Jun 18, 2025
Finian O'Shea Wells Fargo	Wells Fargo	Hold Initiates $15	Hold	Initiates	$15	-0.73%	Jun 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.17B

Increased by 71.48%

from 684.03M

Revenue Next Year

1.53B

Increased by 30.52%

from 1.17B

EPS This Year

1.33

Decreased by -12.29%

from 1.52

EPS Next Year

1.45

Increased by 8.71%

from 1.33

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	173.21M	354.14M	494.85M	683.81M	684.03M	1.17B	1.53B	1.53B
Revenue Growth	106.91%	104.46%	39.73%	38.19%	0.03%	71.48%	30.52%	0.20%
EPS	1.43	3.05	0.09	1.80	1.52	1.33	1.45	1.33
EPS Growth	70.78%	113.35%	-97.05%	1,900.02%	-15.56%	-12.29%	8.71%	-8.01%
Forward PE	-	-	-	-	-	11.33	10.43	11.33
No. Analysts	-	-	-	-	-	3	3	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.3B	1.8B	1.6B
Avg	1.2B	1.5B	1.5B
Low	1.1B	1.3B	1.5B

Revenue Growth

Revenue Growth	2025	2026	2027
High	89.0%	49.2%	4.2%
Avg	71.5%	30.5%	0.2%
Low	56.1%	14.1%	-2.7%

EPS Forecast

EPS	2025	2026	2027
High	1.51	1.72	1.39
Avg	1.33	1.45	1.33
Low	1.18	1.21	1.29

EPS Growth

EPS Growth	2025	2026	2027
High	-0.5%	29.2%	-4.4%
Avg	-12.3%	8.7%	-8.0%
Low	-22.6%	-9.6%	-10.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.